Document 2584 DOCN M94A2584 TI Trends in antimicrobial susceptibility patterns for N. gonorrhoeae in Kumasi, Ghana. DT 9412 AU Addy PA; Dept. of Clinical Microbiology, UST School of Medical Sciences,; Kumasi, Ghana. SO Int Conf AIDS. 1994 Aug 7-12;10(1):270 (abstract no. PB0508). Unique Identifier : AIDSLINE ICA10/94369991 AB OBJECTIVE: The study aims to determine the susceptibility patterns of seven (7) oft-prescribed antimicrobial agents for the treatment of gonorrhoea in Kumasi, Ghana. METHODS: One thousand, one hundred and eighty-seven (1187) patients from whom specimens (high vaginal, cervical and urethral swabs) containing Gram negative intracellular diplococci (GNID) amidst polyphonuclear leukocytes were identified constituted the study population whilst the specimen, the study material. Identity of N. gonorrhoeae was confirmed by colonial morphology, positive oxidase test and sugar fermentation pattern. Penicillinase producing N. gonorrhoeae (PPNG) strains were determined by the Intralactam Strip method. Minimal Inhibitory Concentrations (MICs) of seven (7) antimicrobial agents were determined by the agar plate dilution method. RESULTS: Of 1187 N. gonorrhoeae strains isolated, 93.93% were PPNG. The disc diffusion Antibiotic sensitivity test results showed that Ceftriaxone (100%) and Norfloxacin (99.50%) were the most effective antimicrobials against gonorrhoea, inhibiting all 300 selected PPNG strains at MICs of < or = 0.03 mg/L. and < or = 0.5 mg/L., respectively. Over 60% of the isolates were sensitive to Erythromycin, Spectinomycin, and Tetracycline. Isolated PPNG as well as non-PPNG strains, were 100% resistant to Septrin. With Penicillin, only 72 non-PPNG strains were inhibited at a MIC of 32.0 mg/L. Erythromycin, Tetracycline and Spectinomycin inhibited all 300 selected PPNG strains at MICs of < or = 32.0 mg/L., < or = 4.0 mg/L. and < or = 16.0 mg/L., respectively. DISCUSSIONS AND CONCLUSIONS: There is a high incidence of PPNG in Ghana. A review of the current Gonorrhoea Treatment Regimen needs be undertaken. Suggestions to this end have been made. DE Antibiotics/*THERAPEUTIC USE Ceftriaxone/THERAPEUTIC USE Comparative Study Female Ghana Gonorrhea/*DRUG THERAPY/MICROBIOLOGY Human Male Microbial Sensitivity Tests Neisseria gonorrhoeae/*DRUG EFFECTS Norfloxacin/THERAPEUTIC USE MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).